Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[CD8-positive diffuse large B-cell lymphoma].

M Noguchi1, N Sakamoto, K Okumura

  • 1Department of Hematology, Juntendo University School of Medicine.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of cyclin D-dependent kinase activity in rat liver regeneration.

Biochemical and biophysical research communications·1998
Same author

Molecular characterization of a glyoxysomal long chain acyl-CoA oxidase that is synthesized as a precursor of higher molecular mass in pumpkin.

The Journal of biological chemistry·1998
Same author

Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus.

Biochemical and biophysical research communications·1998
Same author

Novel structural difference between nopaline- and octopine-type trbJ genes: construction of genetic and physical map and sequencing of trb/traI and rep gene clusters of a new Ti plasmid pTi-SAKURA.

Biochimica et biophysica acta·1998
Same author

Soluble vascular cell adhesion molecule-1 in perennial allergic rhinitis.

Acta oto-laryngologica·1998
Same author

Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma: a FISH and FCM analysis of 20 cases.

Digestive diseases and sciences·1998
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Recent advances in management of systemic AL amyloidosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Treatment strategies for relapsed or refractory multiple myeloma: proposals for optimal treatment sequencing].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
See all related articles

This case report details the first known instance of CD8+ diffuse large B-cell lymphoma (DLBL). The patient achieved remission after salvage chemotherapy and autologous stem cell transplant.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Diffuse large B-cell lymphoma (DLBL) is an aggressive non-Hodgkin lymphoma.
  • CD8+ DLBL is a rare subtype with distinct immunophenotypic characteristics.
  • Understanding rare DLBL subtypes is crucial for effective treatment strategies.

Observation:

  • A 63-year-old female presented with relapsed DLBL.
  • Biopsy revealed a CD8+ DLBL immunophenotype (CD8+, CD19+, CD20+, CD25+, lambda+).
  • The patient was an HTLV-1 carrier, but HTLV-1 integration was not detected in lymphoma cells.

Findings:

  • The patient was diagnosed with CD8+ DLBL, clinical stage IA.
  • Salvage chemotherapy led to a response.
  • Autologous peripheral blood stem cell transplantation resulted in complete remission.

Related Experiment Videos

Implications:

  • This is the first reported case of CD8+ DLBL.
  • Highlights the importance of detailed immunophenotyping for rare lymphoma subtypes.
  • Suggests that CD8+ DLBL may be treatable with current therapeutic approaches, including stem cell transplantation.